Ken glad you are mentioning NPHC (.93/$200 Mil Mkt Cap) as I have learned to respect your opinions, what I can't however understand is their exclusive US distributor XCHO is being locked down at about 4 mil mkt cap.
I suspected a few weeks ago the company might be selling shares to raise the $1 mil its plans to spend to introduce Cobraxin to the mkt place. Now I am puzzled.
I own both an I agree the world needs a better pain reliever. I hope this product will fill that need.
Serendipity is the effect by which one accidentally discovers something fortunate, especially while looking for something entirely unrelated.